Assessment of the genotoxic potential of indirect chemical mutagens in HepaRG cells by the comet and the cytokinesis-block micronucleus assays.

Many chemical carcinogens require metabolic activation to form genotoxic compounds in human. Standard in vitro genotoxicity assays performed with activation systems, such as rat liver S9, are recognised to lead to a high number of false positives. The aim of this study was to evaluate the suitability of differentiated human hepatoma HepaRG cells as an in vitro model system for the detection of DNA damage induced by promutagens using the comet and the cytokinesis-block micronucleus assays. Several promutagens were tested, including aflatoxin B1 (AFB1), benzo[a]pyrene (B[a]P), acrylamide, N-nitrosodimethylamine (NDMA), cyclophosphamide (CPA), 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Cytotoxicity of these compounds was assessed by measuring lactate dehydrogenase leakage. A 24 h exposure was generally needed to obtain an obvious positive response in differentiated HepaRG cells in the comet and in the cytokinesis-block micronucleus assays. Comet formation was observed with all compounds except IQ. B[a]P, CPA and AFB1 showed a dose-dependent increase in micronucleated cells, whereas no increase was observed with PhIP, IQ and acrylamide. These preliminary data on genotoxicity in differentiated HepaRG cells are promising but more chemicals must be tested to determine the ability of HepaRG cells to assess genotoxicity of chemicals in humans.

[1]  M. Chagnon,et al.  Use of HepG2 cell line for direct or indirect mutagens screening: comparative investigation between comet and micronucleus assays. , 2003, Mutation research.

[2]  G. Pfeifer,et al.  Genotoxicity of acrylamide and glycidamide. , 2004, Journal of the National Cancer Institute.

[3]  V. Mersch-Sundermann,et al.  Ethanol enhanced the genotoxicity of acrylamide in human, metabolically competent HepG2 cells by CYP2E1 induction and glutathione depletion. , 2008, International journal of hygiene and environmental health.

[4]  Raffaella Corvi,et al.  Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop. , 2008, Mutation research.

[5]  F. Guengerich,et al.  Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. , 1982, Biochemistry.

[6]  J. Hilton.  Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells. , 1984, Biochemical pharmacology.

[7]  C. Belloir,et al.  Protective effects of garlic sulfur compounds against DNA damage induced by direct- and indirect-acting genotoxic agents in HepG2 cells. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  Liping Jiang,et al.  Genotoxicity of acrylamide in human hepatoma G2 (HepG2) cells. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  A. Guillouzo,et al.  Running title page Running title : Functional stability of CYP P 450 enzymes in HepaRG cells , 2009 .

[10]  B. Drénou,et al.  Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor , 2007, Hepatology.

[11]  David Kirkland,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. , 2005, Mutation research.

[12]  Hayley S. Brown,et al.  Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.

[13]  A. Guillouzo,et al.  Functional expression, inhibition and induction of CYP enzymes in HepaRG cells. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[14]  Catherine Ribault,et al.  Highly efficient gene transfer into hepatocyte‐like HepaRG cells: New means for drug metabolism and toxicity studies , 2010, Biotechnology journal.

[15]  Raffaella Corvi,et al.  How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. , 2007, Mutation research.

[16]  R Scott Obach,et al.  Strategy for genotoxicity testing--metabolic considerations. , 2007, Mutation research.

[17]  C. Davis,et al.  Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats. , 1993, Carcinogenesis.

[18]  R. Obach,et al.  Comparison of metabolite profiles generated in Aroclor‐induced rat liver and human liver subcellular fractions: Considerations for in vitro genotoxicity hazard assessment , 2008, Environmental and molecular mutagenesis.

[19]  R. Tice,et al.  Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing , 2000, Environmental and molecular mutagenesis.

[20]  Tommy B Andersson,et al.  Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies , 2008, Drug Metabolism and Disposition.

[21]  André Guillouzo,et al.  Evolving concepts in liver tissue modeling and implications for in vitro toxicology , 2008, Expert opinion on drug metabolism & toxicology.

[22]  C. Helma,et al.  Single-cell gel electrophoresis assays with human-derived hepatoma (Hep G2) cells. , 1999, Mutation research.

[23]  R. Edwards,et al.  Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[24]  R. Sinha,et al.  Excretion of the N(2)-glucuronide conjugate of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in urine and its relationship to CYP1A2 and NAT2 activity levels in humans. , 2002, Carcinogenesis.

[25]  H. Ohgaki,et al.  Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. , 1984, Carcinogenesis.

[26]  D. Nebert,et al.  Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. , 2004, Molecular pharmacology.

[27]  Lutz Müller,et al.  Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.

[28]  V. Mersch-Sundermann,et al.  Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. , 2004, Toxicology.

[29]  J. H. Kim,et al.  Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. , 1998, Carcinogenesis.

[30]  M. Fenech,et al.  HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. , 2003, Mutation research.

[31]  M. Fenech,et al.  Report from the In Vitro Micronucleus Assay Working Group , 2003, Mutation research.

[32]  André Guillouzo,et al.  EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS , 2006, Drug Metabolism and Disposition.

[33]  Raymond R Tice,et al.  Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. , 2007, Mutation research.

[34]  A. Glynn,et al.  Dietary intake of acrylamide in Sweden. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[35]  Valérie Fessard,et al.  Long-Term Functional Stability of Human HepaRG Hepatocytes and Use for Chronic Toxicity and Genotoxicity Studies , 2008, Drug Metabolism and Disposition.

[36]  K. Kohn.  Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. , 1977, Cancer research.

[37]  Volker Mersch-Sundermann,et al.  Genotoxic effects of dietary and lifestyle related carcinogens in human derived hepatoma (HepG2, Hep3B) cells. , 2004, Mutation research.

[38]  M. Jägerstad,et al.  Carcinogenic heterocyclic amines in model systems and cooked foods: a review on formation, occurrence and intake. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[39]  S. Venitt,et al.  Heterocyclic aromatic amines induce DNA strand breaks and cell transformation. , 1999, Carcinogenesis.

[40]  F. Gonzalez,et al.  A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. , 1991, Chemical research in toxicology.

[41]  Christian Trepo,et al.  Infection of a human hepatoma cell line by hepatitis B virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. F. Weber,et al.  Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. , 1993, Cancer research.

[43]  F. Darroudi,et al.  Genotoxic effects of heterocyclic aromatic amines in human derived hepatoma (HepG2) cells. , 1999, Mutagenesis.

[44]  C. Helma,et al.  Evaluation of the single cell gel electrophoresis assay with human hepatoma (Hep G2) cells. , 2000, Mutation research.

[45]  G Williamson,et al.  Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. , 1998, Mutation research.

[46]  P. Fournier.  [Biotransformation of dimethylnitrosamine]. , 1990, Journal de toxicologie clinique et experimentale.